Humacyte, Inc. (HUMA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Humacyte, Inc. (HUMA)
Company Research
Source: Seeking Alpha
Laura Niklason - Founder, President, CEO & Director Dale Sander - CFO, Chief Corporate Development Officer & Treasurer Conference Call Participants Matthew Miksic - Barclays Bank PLC, Research Division Presentation Matthew Miksic Barclays Bank PLC, Research Division All right. Well, we are a couple of minutes into our time here. So we're going to have to talk fast, Laura. Laura Niklason Founder, President, CEO & Director Okay. Matthew Miksic Barclays Bank PLC, Research Division I am very pleased to have with us here at our conference Humacyte. Laura Niklason, Dr. Laura Niklason, Founder, President and Chief Executive Officer; and Dale Sander, CFO. So thank you for coming. Question-and-Answer Session Matthew Miksic Barclays Bank PLC, Research Division Just a quick snippet of history. I've told you before, I think we've met a long time ago in very early stages and I was fascinated by the technology and a lot of things happened from that meeting to like
Show less
Read more
Impact Snapshot
Event Time:
HUMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HUMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HUMA alerts
High impacting Humacyte, Inc. news events
Weekly update
A roundup of the hottest topics
HUMA
News
- Humacyte (HUMA) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $25.00 price target on the stock.MarketBeat
- Humacyte Submits Marketing Authorization Application for Symvess® in Israel for Vascular Trauma Repair [Yahoo! Finance]Yahoo! Finance
- Humacyte Submits Marketing Authorization Application for Symvess® in Israel for Vascular Trauma RepairGlobeNewswire
- Humacyte, Inc. (HUMA) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]Seeking Alpha
- Humacyte To Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
HUMA
Earnings
- 11/12/25 - Beat
HUMA
Sec Filings
- 1/9/26 - Form SCHEDULE
- HUMA's page on the SEC website